Ethanol → HCID 10194514, compound
Reaction equation
[CH2:1]([OH:3])[CH3:2].[H-].[Na+].Br[C:7]1[CH:8]=[C:9]([CH:30]=[CH:31][N:32]=1)[C:10]([NH:12][C:13]1[S:14][C:15]2[C:21]([N:22]3[CH2:27][CH2:26][O:25][CH2:24][CH2:23]3)=[CH:20][CH:19]=[C:18]([O:28][CH3:29])[C:16]=2[N:17]=1)=[O:11]>O1CCOCC1>[CH2:1]([O:3][C:7]1[CH:8]=[C:9]([CH:30]=[CH:31][N:32]=1)[C:10]([NH:12][C:13]1[S:14][C:15]2[C:21]([N:22]3[CH2:23][CH2:24][O:25][CH2:26][CH2:27]3)=[CH:20][CH:19]=[C:18]([O:28][CH3:29])[C:16]=2[N:17]=1)=[O:11])[CH3:2]Participants
Reactant 3
Product 1
Reagents, catalysts & solvents 1
Conditions
- Temperature
- 50 °C
Procedure
To a stirred solution of 0.52 ml (8.90 mmol) ethanol in 30 ml dioxane at room temperature was added 486 mg (11.1 mmol) sodium hydride (55% dispersion in mineral oil) and the mixture heated at 50° C. for 30 minutes. 1.00 g (2.23 mmol) 2-bromo-N-(4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl)-isonicotinamide was then added and the mixture heated at 115° C. for 72 h. The reaction mixture was then cooled to room temperature and concentrated in vacuo. The residue was resuspended in dichloromethane, and washed sequentially with water and saturated brine. The organic phase was then dried over sodium sulfate and concentrated in vacuo. The residue was resuspended in methanol and concentrated in vacuo to 2 ml, 20 ml ether added, and the resulting crystals were collected by filtration and dried in vacuo to afford 410 mg (44%) 2-ethoxy-N-(4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl)-isonicotinamide as a light yellow crystalline solid.
Workup
- temperaturethe mixture heated at 115° C. for 72 h
- temperatureThe reaction mixture was then cooled to room temperature
- concentrationconcentrated in vacuo
- washwashed sequentially with water and saturated brine
- dry with materialThe organic phase was then dried over sodium sulfate
- concentrationconcentrated in vacuo
- concentrationconcentrated in vacuo to 2 ml, 20 ml ether
- additionadded
- filtrationthe resulting crystals were collected by filtration
- customdried in vacuo
Sources & evidence
- ORD record
- ord-039c4b42591a4ee18537d8c884b6aeda
- Source dataset
- uspto-grants-2003_09
- Patent number
- US06620811B2
Reaction notes
Loading…